Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

1.7K
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
1.7K
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

3.0K
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
3.0K
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

1.5K
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
1.5K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.2K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.2K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

761
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
761
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

628
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
628

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Audiological Findings in Hemodialysis Patients.

Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia·2025
Same author

Obstructive oligo-anuria revealing pelvic gynecological cancers, analysis of a series of 102 cases.

Annals of medicine and surgery (2012)·2022
Same author

Fanconi syndrome induced by tenofovir: A case report.

Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia·2016
Same author

Profile of living related kidney donors: a single center experience.

Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia·2010
Same author

[Kidney transplantation in a patient with haemophilia A].

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2009
Same author

[Surgical treatment of secondary hyperparathyroidism in chronic renal failure. Report of 57 cases].

La Tunisie medicale·2008

Related Experiment Video

Updated: Mar 24, 2026

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
03:47

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients

Published on: October 25, 2024

749

[Tuberculosis in hemodialysis]

K Zahiri1, B Ramdani, K Hachim

  • 1Service de néphrologie et d'hémodialyse, CHU Ibn Rochd, Casablanca, Maroc.

Nephrologie
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Tuberculosis in hemodialysis patients often presents with extrapulmonary symptoms, particularly lymph node involvement. Prompt diagnosis and a combination treatment regimen of isoniazid, rifampicin, and pyrazinamide are crucial for recovery.

More Related Videos

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.4K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

9.2K

Related Experiment Videos

Last Updated: Mar 24, 2026

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
03:47

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients

Published on: October 25, 2024

749
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.4K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

9.2K

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Public Health

Context:

  • Tuberculosis (TB) poses a significant health challenge, especially in vulnerable populations.
  • Hemodialysis patients represent a unique group with altered immune responses, increasing susceptibility to infections like TB.
  • Understanding TB's specific manifestations in this population is vital for timely diagnosis and effective management.

Purpose:

  • To describe the distinct clinical features of tuberculosis in patients undergoing periodic hemodialysis.
  • To highlight the diagnostic challenges and confirmation methods for tuberculosis in this cohort.
  • To evaluate the efficacy of a standard anti-tuberculosis treatment regimen in hemodialysis patients.

Summary:

  • A retrospective study analyzed 32 cases of tuberculosis among 203 hemodialysis patients (15.8%) between 1983 and 1996.
  • Tuberculosis presented with frequent extrapulmonary localizations (50%), notably lymph node involvement, and diagnostic difficulties.
  • Diagnosis was confirmed bacteriologically in 18.7% and histologically in 43.8% of cases.
  • Treatment with isoniazid, rifampicin, and pyrazinamide resulted in an 87.5% recovery rate, serving as a diagnostic confirmation in some instances.

Impact:

  • This study underscores the importance of considering tuberculosis in hemodialysis patients presenting with non-specific symptoms.
  • Findings emphasize the need for heightened diagnostic vigilance and tailored management strategies for TB in renal patients.
  • The successful treatment outcomes highlight the effectiveness of standard anti-TB therapy, even in this immunocompromised population.